Delivery Order SPE2DR25D1103-SPE2DR26FF114
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,246.76 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, which carries a firm fixed price structure, was competitively awarded without a set-aside designation and is scheduled for completion by February 20, 2026. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order was issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $63,705.00 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract was competitively awarded without set-aside restrictions and carries a firm fixed-price structure, with performance scheduled for completion by February 12, 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $6,718.61 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on January 28, 2026, is scheduled for completion by February 19, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the contractor. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $11,630.70 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, effective January 7, 2026, with an ultimate completion date of January 29, 2026, represents a firm fixed-price procurement with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,370.50 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by February 5, 2026. The products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award represents a task order against AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $147,806.89 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract is firm fixed price with no set-aside designation, issued on December 30, 2025, and scheduled for ultimate completion by January 22, 2026. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as one of the nation's largest...
- The Defense Logistics Agency awarded a delivery order valued at $3,370.11 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents, with an ultimate completion date of February 20, 2026. This firm fixed-price, non-set-aside contract was awarded on January 29, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $7,085.33 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of January 7, 2026. This delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $20,642.20, with an ultimate completion date of August 26, 2025. This non-set-aside competitive award is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which is valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $183,470.40 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price, non-set-aside contract was awarded on January 20, 2026, with an ultimate completion date of February 10, 2026. The vaccine will be delivered to the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FF114Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,616.85 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract was awarded on February 3, 2026, with an ultimate completion date of February 25, 2026, under firm fixed-price terms with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a single-award vehicle valued at $999,999,999.00 through December 2026 that provides comprehensive global pharmaceutical support for military healthcare programs. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The company competes on a full and open basis for federal contracts and has demonstrated extensive capability in fulfilling diverse pharmaceutical supply requirements through its IDC vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 2/2/26 |